Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Aug;40(8):1623-1629.
doi: 10.1097/IAE.0000000000002648.

IN VIVO OBSERVATION OF RETINAL VASCULAR DEPOSITS USING ADAPTIVE OPTICS IMAGING IN FABRY DISEASE

Affiliations
Multicenter Study

IN VIVO OBSERVATION OF RETINAL VASCULAR DEPOSITS USING ADAPTIVE OPTICS IMAGING IN FABRY DISEASE

Andrea Sodi et al. Retina. 2020 Aug.

Abstract

Purpose: To report a novel finding in patients with Fabry disease, that is, the observation by adaptive optics ophthalmoscopy of intracellular lipidic deposits in retinal vessels.

Methods: Observational two-center case series. Eighteen patients with genetically proven Fabry disease underwent flood-illumination adaptive optics ophthalmoscopy imaging (rtx1; Imagine Eyes, Orsay, France) of retinal vessels.

Results: Fourteen patients (78% of all patients; 7 of the 10 women and 7 of the 8 men) showed paravascular punctuate or linear opacities in both eyes. In the least-affected patients, these were seen only in the wall of precapillary arterioles as discrete spots of 5 µm to 10 µm large, whereas in those more severely affected, capillaries and first-order vessels were also involved with diffuse opacification of the wall. These deposits sometime showed a striated pattern, suggesting colocalization with vascular smooth muscle cells.

Conclusion: Adaptive optics ophthalmoscopy of retinal vessels may be of interest for patients with Fabry disease, providing noninvasive, gradable evaluation of microvascular involvement.

PubMed Disclaimer

References

    1. Germain DP. Fabry disease. Orphanet J Rare Dis 2010;5:30.
    1. El-Abassi R, Singhal D, England JD. Fabry disease. J Neurol Sci 2014;344:5–19.
    1. Germain DP, Poenaru L. Fabry disease: identification of novel alpha-galactosidase mutation and molecular carrier detection by use of fluorescent chemical cleavage of mismatches. Biochem Biophys Res Commun 1999;257:708–713.
    1. Gal A, Beck M, Höppner W, et al. Clinical utility gene card for: fabry disease—update 2016. Eur J Hum Genet 2017;25:e1–e3.
    1. Pitz S, Kalkum G, Arash L, et al. Ocular signs correlate well with disease severity and genotype in Fabry disease. PLoS One 2015;10:e0120814.

Publication types